MedMira Wins Government Tender in Russia
MedMira Inc. announced that it has won an official government tender in the Republic of Tatarsan with its Multiplo(TM) Rapid HBV/HIV/HCV Antibody Test (Multiplo HBV/HIV/HCV). This success is the first in the Company's drive to penetrate the government tender market in the Russian Federation and former CIS states with its 3-in-1 test. This achievement is a direct result of the ongoing efforts of its Russian distributor and the World Trade Center in Koeln, Germany.
The Republic of Tatarstan is situated in the center of the Russian Federation on the East-European Plain at the confluence of the two greatest rivers - the Volga and the Kama. One of the most economically developed republics of the Russian Federation, the Republic of Tatarstan is located in the centre of the largest industrial region of the Russian Federation, at the intersection of most important highways, connecting East and West, North and South of the country. The Republic of Tatarstan boasts a wealth of natural resources, including crude oil, land, and water resources, powerful and diversified industry, high intellectual potential and qualified labour. In a total population of approximately 4 million, representatives of over 70 nationalities reside in the Republic of Tatarstan, with Tatars and Russians being the most numerous.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.